Potent, selective STAT3 inhibitors have been somewhat elusive to develop as many groups over time have attempted to target STAT3 both as an important target within the tumour itself as well as the role it plays in the tumour microenvironment.13, 48. This evidence concerns the gene STAT3 and neoplasm.